Maze Therapeutics Inc (MAZE) Stock Price, Quote, News & History

MAZENASDAQ
$24.67
0.070.28%
At close: Sep 11, 5:00 PM EST
$24.67
0.070.28%
Pre-Market: 4:00 AM EST

Maze Therapeutics (MAZE) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-106.54M
Investing Cash Flow (TTM)
-292.50M
Financing Cash Flow (TTM)
337.14M
Free Cash Flow (TTM)
-106.84M
Capital Expenditure (TTM)
-302.00K
Net Change in Cash (TTM)
-61.90M

Analyst Trends and Forecast

5
Mar
1
Apr
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.02B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
65.53
PB Ratio (TTM)
3.03
Earnings Yield % (TTM)
-9.88%
Earnings Yield % (FWD)
-13.24%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$8.16

Company Debt

Total Debt
$38.96M
LT Debt
$38.96M
LT Debt Issuance (TTM)
$39.40M
LT Debt Repayment (TTM)
-
Total Cash
$202.64M
Debt to Equity
0.13
Issuance of Debt (TTM)
$39.40M
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$24.67
Volume / Avg.
0 / 555.58K
Day Range
- - -
52 Wk Range
22.01 - 53.65
Market Cap
$1.37B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
35
Short Interest
12%
Days to Cover
16.05

About

Sector
Health Care
Industry
Pharmaceuticals
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Maze Therapeutics (MAZE) stock?

A

You can purchase shares of Maze Therapeutics (NASDAQ:MAZE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Maze Therapeutics (MAZE) competitors?

Q

What is the forecast, or price target, for Maze Therapeutics (MAZE) stock?

A

Maze Therapeutics has a consensus price target of $63.78.

Q

What is the current price for Maze Therapeutics (MAZE)?

A

The stock price for Maze Therapeutics (NASDAQ: MAZE) is $24.67 last updated September 14, 2026 at 4:00 PM EDT.

Q

Does Maze Therapeutics (MAZE) pay a dividend?

A

There are no upcoming dividends for Maze Therapeutics.

Q

When is Maze Therapeutics (NASDAQ:MAZE) reporting earnings?

A

Maze Therapeutics does not have any upcoming earnings scheduled.

Q

Is Maze Therapeutics (MAZE) going to split?

A

There is no upcoming split for Maze Therapeutics.

Q

What sector and industry does Maze Therapeutics (MAZE) operate in?

A

Maze Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.